Literature DB >> 9784862

Eponemycin analogues: syntheses and use as probes of angiogenesis.

N Sin1, L Meng, H Auth, C M Crews.   

Abstract

Derivatives of the epoxy-beta-aminoketone containing natural product eponemycin have been prepared in order to study the molecular mode of action of this anti-angiogenic compound. Synthesis and use of a biotinylated dihydroeponemycin analogue demonstrated that dihydroeponemycin forms a covalent adduct with at least two intracellular proteins in human endothelial cells. Pretreatment of cells with a five equivalent excess of dihydroeponemycin precluded biotin-dihydroeponemycin binding indicating a specific interaction between natural product and the target proteins. This biotin-dihydroeponemycin derivative will prove useful in the purification and identification of eponemycin receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784862     DOI: 10.1016/s0968-0896(98)00089-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.

Authors:  I R Garrett; D Chen; G Gutierrez; M Zhao; A Escobedo; G Rossini; S E Harris; W Gallwitz; K B Kim; S Hu; C M Crews; G R Mundy
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 2.  Target profiling of small molecules by chemical proteomics.

Authors:  Uwe Rix; Giulio Superti-Furga
Journal:  Nat Chem Biol       Date:  2009-09       Impact factor: 15.040

3.  Development and characterization of proteasome inhibitors.

Authors:  Kyung Bo Kim; Fabiana N Fonseca; Craig M Crews
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

4.  Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1.

Authors:  Y Zhang; E C Griffith; J Sage; T Jacks; J O Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 5.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

6.  Glyceraldehyde 3-phosphate dehydrogenase is a cellular target of the insulin mimic demethylasterriquinone B1.

Authors:  Hyunsoo Kim; Liu Deng; Xin Xiong; William D Hunter; Melissa C Long; Michael C Pirrung
Journal:  J Med Chem       Date:  2007-06-27       Impact factor: 7.446

7.  Characterization of a novel mammalian phosphatase having sequence similarity to Schizosaccharomyces pombe PHO2 and Saccharomyces cerevisiae PHO13.

Authors:  MacKevin I Ndubuisil; Benjamin H B Kwok; Jonathan Vervoort; Brian D Koh; Mikael Elofsson; Craig M Crews
Journal:  Biochemistry       Date:  2002-06-18       Impact factor: 3.162

8.  De novo biosynthesis of terminal alkyne-labeled natural products.

Authors:  Xuejun Zhu; Joyce Liu; Wenjun Zhang
Journal:  Nat Chem Biol       Date:  2014-12-22       Impact factor: 15.040

Review 9.  From bortezomib to other inhibitors of the proteasome and beyond.

Authors:  Daniela Buac; Min Shen; Sara Schmitt; Fathima Rani Kona; Rahul Deshmukh; Zhen Zhang; Christine Neslund-Dudas; Bharati Mitra; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 10.  The proteomics big challenge for biomarkers and new drug-targets discovery.

Authors:  Rocco Savino; Sergio Paduano; Mariaimmacolata Preianò; Rosa Terracciano
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.